So what do the numbers say? First lets see if there was any difference in the actual treatment. Definitely. In the restrictive group, 51% of patients required transfusion, vs 86% in the liberal group. Sizeable difference. Now in terms of outcomes:a. rebleeding decreased: 10% vs 16%b. 6 week survival was better: 95% vs 91%c. less adverse events: 40% vs 48%But you know what, even if we throw out all the above, the absence of any difference would result in the same conclusion: there is no advantage to a higher hemoglobin goal in GI bleed.